ArticleFrontiers in oncology2025

MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma.

Francesca Bufalieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.